COMPASS Pathways (CMPS) Insider Trading & Ownership $7.28 -0.12 (-1.62%) (As of 10:26 AM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends COMPASS Pathways (NASDAQ:CMPS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.25%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$1.82 M CMPS Insider Buying and Selling by Quarter Ad Chaikin AnalyticsNew September Stock WarningSeptember is the most volatile month of the year for stocks. And after the brutal tech selloff, one Wall Street veteran, who served more than 50 years alongside the likes of Paul Tudor Jones and George Soros, just announced: "This is only the beginning."To hear the name and ticker of this doomed AI stock, 100% free, click here. COMPASS Pathways Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/2/2024George Jay GoldsmithMajor ShareholderSell9,621$8.29$79,758.09 4/16/2024George Jay GoldsmithMajor ShareholderSell23,881$8.53$203,704.93 4/1/2024George Jay GoldsmithMajor ShareholderSell25,750$8.96$230,720.00 3/28/2024Ekaterina MalievskaiaMajor ShareholderSell25,750$8.65$222,737.50 3/12/2024George Jay GoldsmithDirectorSell15,740$10.58$166,529.20 2/26/2024Ekaterina MalievskaiaDirectorSell17,765$10.45$185,644.25 Imminent FDA Decision Could End Obesity in America... (Ad)This drug could end obesity in America... ...and spark a 224,000% sales surge for one tiny micro-cap stock. Channelnomics says it "Could have a greater impact on the world than artificial intelligence."Get the name of this stock here >>>2/23/2024Ekaterina MalievskaiaDirectorSell11,862$10.06$119,331.72 2/6/2024Ekaterina MalievskaiaDirectorSell19,853$10.59$210,243.27 1/22/2024George Jay GoldsmithDirectorSell25,750$8.35$215,012.50 1/19/2024George Jay GoldsmithDirectorSell20,205$7.99$161,437.95 12/13/2023Ekaterina MalievskaiaDirectorSell2,855$7.82$22,326.10 (Data available from 1/1/2013 forward) CMPS Insider Trading Activity - Frequently Asked Questions Who is on COMPASS Pathways's Insider Roster? The list of insiders at COMPASS Pathways includes David Y Norton, Ekaterina Malievskaia, and George Jay Goldsmith. Learn more on insiders at CMPS. What percentage of COMPASS Pathways stock is owned by insiders? 4.25% of COMPASS Pathways stock is owned by insiders. Learn more on CMPS's insider holdings. Which COMPASS Pathways insiders have been selling company stock? The following insiders have sold CMPS shares in the last 24 months: Ekaterina Malievskaia ($760,282.84), and George Jay Goldsmith ($1,057,162.67). How much insider selling is happening at COMPASS Pathways? Insiders have sold a total of 199,032 COMPASS Pathways shares in the last 24 months for a total of $1,817,445.51 sold. More Insider Trading Tools from MarketBeat Related Companies: SAGE Insider Trading MGNX Insider Trading RPTX Insider Trading TVTX Insider Trading PRAX Insider Trading LGND Insider Trading MIRM Insider Trading CNTA Insider Trading AKRO Insider Trading RXRX Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: This Is the Top Large-Cap Stock Insiders Are BuyingMatador Resources Insiders Keep Buying Its Stock, Should You?Top 3 Small-Cap Stocks Insiders Are Buying Right Now3 Small Cap Stocks That Insiders Are BuyingMGM Insiders Bet Big on Its Undervalued Stock This page (NASDAQ:CMPS) was last updated on 9/20/2024 by MarketBeat.com Staff From Our PartnersNew President Kamala warningFinancial nightmare coming after election In 2018, one independent research predicted Kamala Harris was on ...Stansberry Research | SponsoredAct by Friday, August 16th, to collect this 22% dividendLet's do a little math here... To double your money at a 3% rate of return, you would need around 23 years....Investors Alley | SponsoredThis Crypto Is Set to Explode in SeptemberWith thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make ...Crypto 101 Media | SponsoredNew September Stock WarningSeptember is the most volatile month of the year for stocks. And after the brutal tech selloff, one Wall St...Chaikin Analytics | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding COMPASS Pathways plc You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share COMPASS Pathways With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
